Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.

Walker S, Meisenberg C, Bibby RA, Askwith T, Williams G, Rininsland FH, Pearl LH, Oliver AW, El-Khamisy S, Ward S, Atack JR.

Anal Biochem. 2014 Jun 1;454:17-22. doi: 10.1016/j.ab.2014.03.004. Epub 2014 Mar 14.

2.

Vaccination with tumor cells pulsed with foreign peptide induces immunity to the tumor itself.

Schlingmann TR, Rininsland FH, Bartholomae WC, Kuekrek H, Lehmann PV, Tary-Lehmann M.

Clin Immunol. 2009 Oct;133(1):45-51. doi: 10.1016/j.clim.2009.06.004. Epub 2009 Jul 9.

3.

A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching.

Stankewicz C, Rininsland FH.

J Biomol Screen. 2006 Jun;11(4):413-22. Epub 2006 Feb 20.

PMID:
16490774
4.

Biocidal activity of a light-absorbing fluorescent conjugated polyelectrolyte.

Lu L, Rininsland FH, Wittenburg SK, Achyuthan KE, McBranch DW, Whitten DG.

Langmuir. 2005 Oct 25;21(22):10154-9.

PMID:
16229539
5.

T cell immunity induced by live, necrotic, and apoptotic tumor cells.

Bartholomae WC, Rininsland FH, Eisenberg JC, Boehm BO, Lehmann PV, Tary-Lehmann M.

J Immunol. 2004 Jul 15;173(2):1012-22.

6.

Granzyme B ELISPOT assay for ex vivo measurements of T cell immunity.

Rininsland FH, Helms T, Asaad RJ, Boehm BO, Tary-Lehmann M.

J Immunol Methods. 2000 Jun 23;240(1-2):143-55.

PMID:
10854609

Supplemental Content

Loading ...
Support Center